SCHEMBL4181647

SCHEMBL4181647

N#C/C(=C\c1cc(Cl)cc(Cl)c1Cl)S(=O)(=O)Nc1ccc(F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HSD17B3 P37058 1/20 0.37
HSD17B2 P37059 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
LMNA P02545 1/20 0.36
ACLY P53396 6/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
IDH1 O75874 1/20 0.34
FLT1 P17948 1/20 0.33
FLT4 P35916 1/20 0.33
KDR P35968 1/20 0.33
TP53 P04637 1/20 0.33
MAOB P27338 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4181650 1.00 PKM (0.37) PKML3MBTL1HSD17B3HSD17B2CA12
SCHEMBL4181652 1.00 PKM (0.37) PKML3MBTL1HSD17B3HSD17B2CA12
SCHEMBL4172698 0.85 PGR (0.42) PKMCA12CA1CA2CA9
SCHEMBL4172703 0.85 PGR (0.42) PKMCA12CA1CA2CA9
SCHEMBL4172704 0.85 PGR (0.42) PKMCA12CA1CA2CA9
SCHEMBL4183592 0.81 TRPA1 (0.48) PKML3MBTL1HSD17B3HSD17B2CA12
SCHEMBL4183602 0.81 TRPA1 (0.48) PKML3MBTL1HSD17B3HSD17B2CA12
SCHEMBL4183597 0.81 TRPA1 (0.48) PKML3MBTL1HSD17B3HSD17B2CA12
SCHEMBL4185563 0.81 PKM (0.55) PKML3MBTL1HSD17B3HSD17B2CA2
SCHEMBL4185571 0.81 PKM (0.55) PKML3MBTL1HSD17B3HSD17B2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US claimed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 PKM 2657/4885L3MBTL1 3476/4885HSD17B3 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.